Pfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020 depending on trials
"Of course we need to see and wait to see how the vaccine's efficacy
and safety is demonstrated, hopefully in the coming months," Nanette
Cocero, the global head of Pfizer Vaccines, said on a conference call.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-aims-for-10-20-mln-doses-of-coronavirus-vaccine-by-end-2020-depending-on-trials/articleshow/75475414.cms
and safety is demonstrated, hopefully in the coming months," Nanette
Cocero, the global head of Pfizer Vaccines, said on a conference call.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-aims-for-10-20-mln-doses-of-coronavirus-vaccine-by-end-2020-depending-on-trials/articleshow/75475414.cms
Comments
Post a Comment